Feature Channels:

social media distr - auto for marked clients

Add to Favorites Subscribe Share
Newswise: Hackensack Meridian Health Center for Discovery and Innovation to Host Genomic Medicine Symposium

Hackensack Meridian Health Center for Discovery and Innovation to Host Genomic Medicine Symposium

Hackensack Meridian Health

The Symposium on February 19 will feature a variety of clinical disorders in which prevention, screening, and treatment can be informed through genomic and epigenomic data.

Channels: Autoimmune Diseases, Cancer, Cell Biology, Children's Health, Genetics, Healthcare,

Released:
17-Jan-2020 11:30 AM EST
Open in New Tab
Comment
Newswise: John Theurer Cancer Center Participating in Early-Phase Study of Immunotherapy-Boosting Treatment

John Theurer Cancer Center Participating in Early-Phase Study of Immunotherapy-Boosting Treatment

Hackensack Meridian Health

Investigators at John Theurer Cancer Center at Hackensack University Medical Center in New Jersey are participating in a first-in-patients clinical trial assessing VE800, a novel bacteria-containing therapy, in combination with the immunotherapy drug nivolumab. Laboratory research has suggested that VE800 may enhance the effectiveness of drugs like nivolumab.

Channels: Cancer, Digestive Disorders, Immunology, Liver Disease, Microbiome, OBGYN,

Released:
16-Jan-2020 1:55 PM EST
Open in New Tab
Comment
Announcement
Newswise: Hackensack University Medical Center First Hospital in New Jersey to Perform Kidney Transplant Using Cutting-Edge, Life-Saving Technology

Hackensack University Medical Center First Hospital in New Jersey to Perform Kidney Transplant Using Cutting-Edge, Life-Saving Technology

Hackensack Meridian Health

Hackensack Meridian Hackensack University Medical Center today announced that it became the first hospital in the New Jersey to perform a kidney transplant with a kidney preserved at its own Organ Preservation Center using the LifePort Kidney Transporter, an ex vivo hypothermic machine preservation technology. Hypothermic machine preservation is a cutting-edge, life-saving technology that increases a kidney’s viability and lifespan, improving patient outcomes.

Channels: Kidney Disease, Surgery, Transplantation,

Released:
16-Jan-2020 1:50 PM EST
Open in New Tab
Comment
Feature
Newswise: Hackensack University Medical Center Participated in Nationwide Study that Finds Three Medications are Safe and Effective in Treating Life-Threatening Seizures

Hackensack University Medical Center Participated in Nationwide Study that Finds Three Medications are Safe and Effective in Treating Life-Threatening Seizures

Hackensack Meridian Health

Hackensack University Medical Center researchers in Emergency Medicine participated in a nationwide study published in the New England Journal of Medicine in November 2019 that concluded that three drugs are equally safe and effective in treating patients with life-threatening seizures called Status Epilepticus (SE). The new study, Established Status Epilepticus Treatment Trial (ESETT), examined three medications commonly administered in the emergency department to treat SE – levetiracetam, fosphenytoin, and valproate – in order to learn which is most effective in treating patients.

Channels: All Journal News, Neuro, NEJM,

Released:
16-Jan-2020 1:50 PM EST
Open in New Tab
Comment
Feature
Newswise: The Center for Dentistry at Hackensack University Medical Center to Offer Free Dental Care through “Give Kids a Smile” Program

The Center for Dentistry at Hackensack University Medical Center to Offer Free Dental Care through “Give Kids a Smile” Program

Hackensack Meridian Health

The Center for Dentistry at Hackensack University Medical Center will be participating in the American Dental Association’s “Give Kids a Smile” program on Friday, February 7. Free preventive and restorative dental care will be offered to children ages 12 and younger by appointment only from 9:00am to 4:00pm at the Hillcrest Building, 60 Second Street, Hackensack.

Channels: Children's Health, Oral Health,

Released:
16-Jan-2020 1:50 PM EST
Open in New Tab
Comment
Research Results
Newswise: Hackensack University Medical Center’s Hospital Earns the Most Certifications of Any Hospital in the Nation

Hackensack University Medical Center’s Hospital Earns the Most Certifications of Any Hospital in the Nation

Hackensack Meridian Health

Hackensack Meridian Hackensack University Medical Center announced today that it earned its 28th The Joint Commission (TJC) Disease Specific Care (DSC) certification, marking the most certifications of any hospital in the nation. TJC awarded the Prematurity program at Joseph M. Sanzari Children’s Hospital at Hackensack University Medical Center with the DSC certification after a rigorous review process. Joseph M. Sanzari Children’s Hospital is the first hospital in the state of New Jersey to earn this esteemed designation.

Channels: Healthcare,

Released:
16-Jan-2020 12:05 PM EST
Open in New Tab
Comment
Announcement
Newswise: 2020 is the Year of the Nurse and Midwife

2020 is the Year of the Nurse and Midwife

University of Pennsylvania School of Nursing

The World Health Organization (WHO) has declared 2020 to be the Year of the Nurse and Midwife and Penn Nursing is joining in on the celebration. We want to help the public – in the Commonwealth of Pennsylvania and beyond – better understand the impact these professions have on health and health care.

Channels: Healthcare, In the Workplace, Nursing,

Released:
15-Jan-2020 2:30 PM EST
Open in New Tab
Announcement
UB_Horizontal_SUNY.png

Brain model offers new insights into damage caused by stroke and other injuries

University at Buffalo

A University at Buffalo neuroimaging researcher has developed a computer model of the human brain that more realistically simulates actual patterns of brain impairment than existing methods. The novel advancement represents the union of two established approaches to create a digital simulation environment that could help stroke victims and patients with other brain injuries by serving as a testing ground for hypotheses about specific neurological damage.

Channels: Artificial Intelligence, Cognition and Learning, Neuro, Technology, All Journal News,

Released:
14-Jan-2020 2:40 PM EST
Open in New Tab
Comment
Announcement
Newswise: John Theurer Cancer Center Investigators Report Effectiveness of New Treatment for Refractory Multiple Myeloma

John Theurer Cancer Center Investigators Report Effectiveness of New Treatment for Refractory Multiple Myeloma

Hackensack Meridian Health

Investigators at John Theurer Cancer Center at Hackensack University Medical Center in New Jersey were part of the CANDOR global phase III clinical trial for patients with refractory (persistent) multiple myeloma. The study was selected as the prestigious plenary presentation at the 61st American Society of Hematology (ASH) Annual Meeting, the world's leading conference for hematologic cancers and blood disorders, held in Orlando in December.

Channels: Blood, Cancer, Healthcare, Clinical Trials, Pharmaceuticals, All Journal News,

Released:
13-Jan-2020 6:05 PM EST
Open in New Tab
Comment
Research Results
Newswise: Hackensack Meridian School of Medicine at Seton Hall University Educator Awarded National Fellowship
Educator Awarded National Fellowship

Hackensack Meridian School of Medicine at Seton Hall University Educator Awarded National Fellowship Educator Awarded National Fellowship

Hackensack Meridian Health

Ofelia Martinez, M.D., M.P.H., was one of only eight recipients of the inaugural Strategic Educators Enhancement Fund (SEEF) Medical Education Research Fellowship.

Channels: Healthcare,

Released:
9-Jan-2020 4:05 PM EST
Open in New Tab
Comment
Research Results

Education



5.93108